Reapplix ApS, developers of the unique LeucoPatch active wound therapy, have today announced that they have received notification that a key patent has been granted in the Japan. The Japanese patent office have granted Reapplix’s patent protecting the unique triple layered structure of LeucoPatch (JP patent no 5802554). Reapplix has strong patent protection across multiple key territories.